CellWell record HH-125088
Modulators of the hepcidin pathway in polycythemia vera and myelofibrosis
Kremyanskaya M; Ginzburg YZ; Hoffman R
Blood ยท 2026
In plain language
This review describes drugs being developed to raise hepcidin in polycythemia vera to control excess red cell production, and to lower hepcidin in myelofibrosis to free iron for erythropoiesis and correct anemia.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-125088
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.